By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

20/20 GeneSystems, Inc. 

9430 Key West Ave

Rockville  Maryland  20850  U.S.A.
Phone: 240-453-6339 Fax: 240-403-0289


SEARCH JOBS








Company News
Study Shows Use Of 20/20 GeneSystems, Inc.’ Breast Cancer Indexsm Molecular Test Substantially Lowers Medical Costs For ER+ Breast Cancer Patients Compared With Standard Management 9/11/2014 10:07:53 AM
Bao Hao Investment Management Co. Affiliate Takes Equity Stake In 20/20 GeneSystems, Inc. 8/21/2014 12:02:56 PM
20/20 GeneSystems, Inc. on Hunt for $5 Million to Broaden Lung Cancer Diagnostic’s Market, Launch in Kidney Cancer, CEO Says 5/20/2013 10:28:27 AM
20/20 GeneSystems, Inc. Announces the Appointment of Joel Kanter, Chairman of the Board, and Two Additional Board Members Raymond Cypess, DVM/Ph.D. and Lawrence Shulman, Esq. 3/18/2013 12:19:39 PM
20/20 GeneSystems, Inc. Awarded $3 Million from National Cancer Institute to Develop Personalized Medicine Tests 10/19/2010 9:56:51 AM
20/20 GeneSystems, Inc. Awarded $3 Million from National Cancer Institute to Develop Personalized Medicine Tests 10/19/2010 8:06:35 AM
20/20 GeneSystems, Inc. Release: New Multiplex Tissue Biomarker Technology Launched to Advance Personalized Medicine 9/14/2010 11:52:33 AM
20/20 GeneSystems, Inc. Licenses Lung Cancer Blood Test to Ortho-Clinical Diagnostics 1/17/2008 9:19:18 AM
National Institute of Standards and Technology Awards $2 Million to 20/20 GeneSystems, Inc. for Innovative Tumor Profiling Technology 10/5/2007 10:30:50 AM
20/20 GeneSystems, Inc.'s Blood Test Predicts Detects Lung Cancer Years Before CT Scan 8/1/2006 11:40:49 AM
//-->